Kyle Kuvalanka is the founder of Goldfinch Biopharma. Goldfinch Biopharma has raised $155M in total funding. Latest round: Series B.
Kyle Kuvalanka served as Chief Financial and Operating Officer at Goldfinch Biopharma, a biotechnology company focused on kidney disease therapeutics. He was involved in the company's closure and managed the process alongside CEO Tony Johnson. Kuvalanka was part of the leadership team that raised $155 million in total funding.
Full founder directory · Investor directory · Company funding database · Fundraising library